Get Social With Us

Challenges and Opportunities for Biosimilars Developers in the US

By: Amy Ritter and Nora Barry of BioPharm International
Reprinted with the permission of BioPharm International, September 2012

In the September 2012 issue of BioPharm International, Dr. Howard Levine, President and Principal Consultant, comments on the implications of FDA’s draft guidance documents on biosimilars development.